ARN22089

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model .


Cat. No.: EX-A8797	Purity: >98%

	Chemical structure of ARN22089

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	500	In-stock
50mg	700	In-stock
100mg	950	In-stock
250mg	1450	In-stock
500mg	get quote	In-stock
1g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2248691-29-2
Purity	>98%
Formula	C23H27N5
Mol Weight	373.494
Color	Off-white to light yellow
State	solid powder
Solubility	DMSO : 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Brindani N, et al. Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer. J Med Chem. 2023;66(8):5981-6001.
CoA	CoA of ARN22089


		Search